Basic Trandate Information

• INN (International Nonproprietary Name): Labetalol
• Brand Names Available In United States: Trandate, Normodyne (discontinued in US as brand; generics available). Tablets commonly available as 100 mg, 200 mg, 300 mg and packaged in bottles of 100 tablets or as unit doses.
• ATC Code: C07AG01
• Forms & Dosages: Oral tablets in 100 mg, 200 mg, 300 mg (400 mg available in some regions). Intravenous solutions: commonly 5 mg/mL and 100 mg/20 mL vials.
• Manufacturers In United States: Generics are supplied by multiple manufacturers and suppliers including Sandoz, Mylan, Apotex and others; original brands have been marketed by GSK and regional companies.
• Registration Status In United States: Generic labetalol hydrochloride is FDA-approved; the Trandate branded product label has been discontinued in the US but generic labetalol HCl remains available.
• OTC / Rx Classification: Prescription-only (Rx)

Instructions, Immediate Warnings, And Daily-Life Integration (Read First)

Do not start, stop, or change trandate (labetalol) without consulting your prescriber.

If you have asthma, a history of obstructive airway disease, severe heart block, or cardiogenic shock, avoid trandate—these are absolute contraindications.

Watch for dizziness, lightheadedness, slow heart rate, low blood pressure, or breathing trouble while on labetalol.

In emergencies such as severe hypotension, bradycardia, shock, or bronchospasm seek immediate medical care—overdose management may require IV fluids, atropine, glucagon, and vasopressors.

Use a pill organizer and set phone reminders to keep dosing consistent when taking trandate tablets.

Carry a wallet card that lists “labetalol (Trandate)” and major contraindications so first responders know your medication history.

Keep scheduled follow-up blood pressure checks and liver-function tests if your clinician recommends them.

Preferable formats: a pre-start screening checklist, a daily medication checklist, and a wallet card template are practical tools to use before and during trandate therapy.

Everyday Use & Best Practices

Morning Vs Evening Dosing

Decide timing based on how trandate affects you rather than by rule-of-thumb.

For most adults the usual oral starting dose is 100 mg twice daily, with maintenance commonly 200–400 mg twice daily and a maximum up to 2,400 mg per day divided into doses.

If you experience daytime dizziness or fatigue on labetalol, shift the larger dose toward the evening to reduce daytime impact.

If trandate causes vivid dreams or excessive sleepiness at night, avoid taking the larger dose in the evening and favor morning dosing instead.

Try to keep a steady schedule with the same two or three times daily timing rather than variable timing to keep blood pressure stable on labetalol tablets.

Taking With Or Without Meals

Trandate tablets may be taken with or without food according to tolerance and convenience.

If you develop nausea on labetalol, take the tablet with a light snack to reduce stomach upset.

For IV use in urgent settings, typical hospital protocols start with a 20 mg slow IV bolus over about two minutes or an infusion at 0.5–2 mg per minute titrated to response.

Practical Tips

• Daily dosing schedule (example): 100 mg in the morning and 100 mg in the evening for initiation; increase per prescriber guidance.
• Use a weekly pillbox and smartphone reminders to support adherence to a labetalol twice daily schedule.
• Keep a small table or note listing oral versus IV timing for emergency care providers.

Safety Priorities

Who Should Avoid It

Absolute contraindications for trandate include bronchial asthma or a history of obstructive airway disease, overt cardiac failure, cardiogenic shock, and second- or third-degree heart block without a pacemaker.

Known hypersensitivity to labetalol or any component is also an absolute contraindication to using trandate tablets or injections.

Use caution with diabetes because beta-blockers like labetalol can mask typical signs of hypoglycemia such as tremor and tachycardia.

People with peripheral vascular disease, significant liver disease, or untreated pheochromocytoma require specialist review before starting labetalol; liver disease in particular increases the risk of hepatotoxicity.

Pregnancy requires specialist management—labetalol is used in some cases for severe hypertension or preeclampsia but only under clinician supervision.

Activities To Limit

Until you know how labetalol affects you, avoid driving, operating heavy machinery, or climbing ladders because dizziness and drowsiness can occur on trandate.

Avoid sudden, vigorous exercise if you develop shortness of breath or chest tightness after starting labetalol tablets or after dose increases.

Avoid excessive alcohol while taking trandate since alcohol can intensify drowsiness and blood-pressure lowering effects.

Practical Checklists

• Pre-start contraindications checklist: asthma/COPD, heart block, overt heart failure, severe bradycardia, pregnancy—discuss with prescriber first.
• “Do Not Do Until Stable” checklist for first 1–2 weeks: no driving, no heavy machinery, avoid alcohol, and monitor BP at home.

Dosage & Adjustments

General Regimen

Typical adult oral initiation is 100 mg twice daily and titration is usually performed every one to two weeks based on blood-pressure response and tolerability.

Maintenance therapy commonly ranges from 200–400 mg twice daily with oral tablet strengths of 100 mg, 200 mg, and 300 mg available.

For hypertensive emergencies, IV labetalol dosing often begins with a 20 mg slow IV bolus over about two minutes and may be repeated or escalated to 40–80 mg every 10 minutes as needed, or given as a continuous infusion at 0.5–2 mg per minute titrated to effect.

Special Cases

Elderly patients should begin at a lower dose and be titrated more slowly because older adults are more susceptible to orthostatic hypotension and falls when taking labetalol.

Renal impairment generally does not require formal dose adjustment for labetalol, but closer monitoring for intensified effects is prudent.

Liver impairment may require dose reduction and careful monitoring because labetalol can accumulate and is associated with rare hepatotoxicity.

Pediatric use is not routinely established for chronic therapy; labetalol may be used in specialist settings for hypertensive crises with weight-based dosing determined by pediatric specialists.

If a dose is missed, take it as soon as remembered unless the next dose is near—do not double up doses of labetalol.

Dosing Table

• Start: 100 mg twice daily (oral).
• Maintenance: 200–400 mg twice daily (oral), adjusted per clinic blood pressure goals.
• Maximum: Up to 2,400 mg per day divided into doses (oral).
• IV emergency: 20 mg slow bolus over ~2 minutes, repeat or use infusion at 0.5–2 mg/min per protocol.

User Testimonials (Patient-Centered Summaries)

Positive Reports

"My daytime spikes settled after switching to labetalol and my clinic adjusted me to trandate 200 mg twice daily." (anonymous)

"The tablet strengths made it easy to find a dose that controlled my BP without too much fatigue." (anonymous)

"In hospital, a slow IV bolus of labetalol calmed my very high pressures quickly and predictably." (anonymous)

Common Challenges

Some patients report dizziness and orthostatic lightheadedness when doses are increased on labetalol tablets.

Fatigue, sleepiness, and occasional nausea are commonly reported early in therapy with trandate.

Rarely, patients experience abnormal liver tests while taking labetalol; clinicians usually check liver function when indicated.

People with asthma or COPD report breathing concerns and should avoid labetalol entirely because of bronchospasm risk.

What To Tell Your Clinician

• Report new or worsening dizziness, syncope, breathlessness, or chest pain immediately.
• Note any persistent nausea, mood change, yellowing of skin or eyes, or dark urine to prompt LFT checks.
• Mention any history of asthma, COPD, or prior liver problems before starting labetalol.

Buying Guide

Pharmacy Sources

In the United States the branded Trandate/Normodyne label is discontinued, but generic labetalol hydrochloride is FDA-approved and widely available in community and mail-order pharmacies.

Common tablet strengths stocked by pharmacies are 100 mg, 200 mg, and 300 mg, and hospital pharmacies maintain IV vials such as 100 mg/20 mL for emergency use.

In our online pharmacy, trandate is available without a prescription, with discreet delivery to United States in 5-14 days.

Price Comparison

To find the best price for labetalol tablets, compare local pharmacy retail prices, certified online pharmacies, and mail-order options.

Use coupon programs, GoodRx-style price comparison tools, and your insurer’s preferred formulary to lower out-of-pocket cost for labetalol generic products.

For hospitalized IV use, institution pricing varies—ask the hospital pharmacy about alternatives such as nicardipine if cost or availability is a concern for acute management.

Sources Comparison

• Local Pharmacy: quick pickup, immediate supply for labetalol 100 mg–300 mg tablets.
• Mail-Order Pharmacy: often lower cost for a 90- or 100-day supply of labetalol generic tablets.
• Hospital Pharmacy: supplies IV labetalol vials for emergency and inpatient care.

What’s Inside & How It Works

Ingredients Overview

The active ingredient in Trandate is labetalol hydrochloride, the International Nonproprietary Name being labetalol.

Tablets typically come in strengths of 100 mg, 200 mg, and 300 mg, with 400 mg available in some countries.

IV solutions for injection are commonly supplied as 5 mg/mL or as 100 mg/20 mL vials depending on the manufacturer.

Excipients vary by manufacturer; check the specific product leaflet if you have allergy concerns to inactive ingredients.

Mechanism Basics

Labetalol is classified under ATC code C07AG01 as a mixed beta-blocker with additional alpha-1 blocking activity.

The drug lowers blood pressure by reducing heart rate and cardiac output via beta blockade while producing peripheral vasodilation through alpha-1 blockade.

This combined action is useful for both chronic oral management of hypertension and for controlled reduction of blood pressure using IV labetalol in acute settings.

Because labetalol blocks beta receptors, it can mask hypoglycemia symptoms in people with diabetes and can worsen bronchospasm in susceptible patients.

Quick Reference

• Routes: Oral tablets and IV injection.
• Strengths: 100 mg, 200 mg, 300 mg tablets; IV 5 mg/mL, 100 mg/20 mL vials.
• Mechanism: Beta-blockade (nonselective) + alpha-1 blockade → decreased heart rate and vasodilation.

Main Indications

Approved Uses

Labetalol is primarily indicated as an antihypertensive agent for chronic hypertension when given orally.

IV labetalol is used for acute blood-pressure reduction in settings such as hypertensive emergencies under institutional protocols.

Standard oral initiation is 100 mg twice daily with titration to effect; IV protocols commonly use 20 mg slow boluses or infusions at 0.5–2 mg per minute.

Off-Label Uses

Labetalol is commonly used in pregnancy for severe hypertension and preeclampsia under specialist oversight, although prescribers weigh risks and benefits for each case.

In pediatrics, labetalol may be used off-label for hypertensive crises in specialist settings, but routine pediatric safety and efficacy for chronic use are not established.

Prescriber Conversation Checklist

• Discuss why labetalol is chosen versus alternatives for your blood-pressure pattern or pregnancy status.
• Confirm monitoring plan for BP, pulse, and liver function if risk factors exist.
• Review contraindications such as asthma, heart block, or heart failure.

Interaction Warnings

Food Interactions

No major food interactions require strict avoidance with labetalol, but alcohol and other CNS depressants can increase drowsiness and hypotensive effects on trandate.

Taking labetalol with a light snack can reduce nausea if it occurs after dosing of labetalol tablets.

Store labetalol tablets at 20°–25°C (68°–77°F) and protect them from moisture and light during transport and at home.

Drug Conflicts

Drugs that lower blood pressure such as ACE inhibitors, ARBs, and other antihypertensives can have additive hypotensive effects when combined with labetalol.

Combining labetalol with other beta-blockers or with non-dihydropyridine calcium-channel blockers like verapamil and diltiazem increases the risk of bradycardia and heart block.

Labetalol is metabolized hepatically and can interact with drugs that affect liver enzymes; monitor closely when co-prescribed with such agents.

In people with diabetes, labetalol may mask adrenergic symptoms of hypoglycemia when used alongside insulin or sulfonylureas.

Interaction Table (By Severity)

• High-risk: Combination with other beta-blockers, verapamil/diltiazem (risk of severe bradycardia/heart block).
• Moderate-risk: Additive hypotension with ACE inhibitors, ARBs, and diuretics.
• Low-risk: Food—not clinically significant interactions; alcohol may intensify effects.

Latest Evidence & Insights

Recent Studies Summary

Regulatory status: generic labetalol HCl is FDA-approved in the United States while Trandate as a brand has been discontinued in the US market; labetalol retains approvals across other regulatory jurisdictions.

Clinical experience supports the use of IV labetalol for controlled, stepwise lowering of blood pressure in appropriate emergencies, and oral labetalol for chronic hypertension management.

Hepatic injury is an uncommon but serious adverse event associated with labetalol and merits clinician attention and liver-function testing when clinically indicated.

Practical Takeaways

Use IV labetalol when a controlled, predictable decrease in blood pressure is required and when mixed alpha/beta blockade is clinically appropriate.

For chronic therapy, slow titration of labetalol reduces the risk of orthostatic episodes and improves tolerability for most patients.

Consider alternative antihypertensive classes (ACE inhibitors, calcium-channel blockers) when asthma, significant peripheral arterial disease, or prior hepatic reactions rule out labetalol.

Monitoring Checklist

• Baseline BP and pulse, repeat within 1–2 weeks after dose changes.
• Baseline LFTs if risk factors present; repeat if symptoms suggest hepatic injury.
• Keep a daily BP log and symptom diary while titrating labetalol.

Alternative Choices

Comparable Drugs

Other beta-blockers used for hypertension include metoprolol, carvedilol, atenolol, and bisoprolol.

Non-beta options commonly used are ACE inhibitors like enalapril, calcium-channel blockers like amlodipine, and agents such as clonidine or hydralazine in specific situations.

For IV urgent blood-pressure control in hospital settings, esmolol, nicardipine, and nitroprusside are widely used alternatives depending on the clinical scenario.

Choosing Based On Situation

In patients with asthma or COPD, avoid labetalol and choose non-beta agents such as a CCB or ACE inhibitor where appropriate.

For pregnancy-related severe hypertension, hydralazine and labetalol are commonly compared; individual patient factors and clinician experience guide the choice.

In heart-failure patients, avoid initiating beta-blockers during uncontrolled decompensated heart failure—specialist guidance is required for selecting the best agent.

Decision Table

• Asthma/COPD → Avoid labetalol → Consider amlodipine or ACE inhibitor.
• Pregnancy (preeclampsia) → Hydralazine or labetalol under specialist care.
• Acute hypertensive emergency → IV labetalol or nicardipine depending on comorbidities.

Regulation Snapshot

Approval & Prescription Status

Labetalol (Trandate) is a prescription-only medicine in markets reviewed.

In the US, the Trandate brand label is discontinued though generic labetalol HCl is FDA-approved and commercially available.

Regulatory approvals across the EU and other regions list labetalol as an antihypertensive agent under ATC C07AG01.

Packaging & Storage

Tablet strengths commonly include 100 mg, 200 mg, and 300 mg with 400 mg available in some regions; packaging ranges from bottles to blister packs depending on the market and manufacturer.

IV vials are typically supplied as 5 mg/mL or 100 mg/20 mL presentations for hospital use.

Store labetalol tablets at 20°–25°C (68°–77°F) with permitted excursions to 15°–30°C and protect them from moisture and light.

Storage Checklist

• Home storage: 20°–25°C, dry place, away from children and direct sunlight.
• Transport: avoid freezing; protect IV solutions from freezing and excessive heat.

FAQ Section

Top Patient Questions

Can I stop trandate suddenly?

No—do not stop labetalol abruptly; a prescriber-guided taper is required to avoid rebound hypertension.

Is it safe in pregnancy?

Labetalol is used under specialist care for severe hypertension and preeclampsia; discuss risks and benefits with your clinician.

What if I miss a dose?

Take the missed dose as soon as you remember unless it is almost time for the next dose; do not double the dose of labetalol.

How soon does it work?

Oral labetalol begins to lower blood pressure within hours to days, while IV labetalol works within minutes when given as a slow bolus or infusion.

What tests are needed?

Regular blood pressure and pulse checks are essential; consider liver function testing if symptoms or risk factors for hepatotoxicity are present.

Quick Answers Checklist

• When to call your clinician: severe dizziness, fainting, difficulty breathing, chest pain, jaundice, or marked bradycardia.
• Keep a record of BP readings and any side effects to discuss at follow-up visits.

Guidelines For Proper Use

Monitoring & Follow-Up

Before starting labetalol, screen for asthma/COPD, heart block, active liver disease, and pregnancy status.

Obtain baseline blood pressure and pulse; consider baseline LFTs if risk factors exist for hepatotoxicity.

Follow-up BP and pulse checks are recommended within one to two weeks after dose changes during titration of labetalol.

Titrate oral doses every one to two weeks as needed for chronic therapy under prescriber supervision.

Keep a home blood-pressure log and maintain pill reminders to support adherence to a labetalol twice daily schedule.

Emergency Steps

Recognize signs of overdose or severe adverse effects such as severe hypotension, profound bradycardia, shock, heart failure signs, or bronchospasm.

Emergency management may include supportive care, IV fluids, atropine for symptomatic bradycardia, glucagon for severe beta-blocker overdose, vasopressors, and respiratory support if required.

For severe allergic reactions like angioedema or anaphylaxis, seek immediate emergency medical attention.

Monitoring Checklist To Carry

• Vitals to monitor: BP, pulse, symptoms of dizziness or breathlessness, and signs of liver dysfunction.
• If This Happens (Emergency Action): severe hypotension → call emergency services; bronchospasm → seek immediate care; severe bradycardia → present to emergency department.

Delivery Across United States